Changeflow GovPing Healthcare Koven BiDop 3 Pocket Doppler Fetal Probe Class ...
Urgent Enforcement Amended Final

Koven BiDop 3 Pocket Doppler Fetal Probe Class II Recall Z-1631-2026

Favicon for changeflow.com FDA: Device Recalls Class II
Filed
Detected
Email

Summary

FDA classified a Class II recall of Koven Technology's BiDop 3 Pocket Doppler (ES-100V3) with BT2M20S8C 2 MHz fetal probe. The device is being recalled because product labeling includes a fetal indication for use that was not cleared under the device's 510(k) premarket notification. The recall affects units distributed nationwide across 16 states including LA, NC, MT, TX, MA, OR, NY, IL, CO, GA, FL, WA, WI, MO, AZ, and IN.

What changed

FDA initiated a Class II recall of Koven Technology's BiDop 3 Pocket Doppler (ES-100V3) and BT2M20S8C fetal probe due to labeling that includes a fetal indication for use without proper 510(k) clearance. The recall number is Z-1631-2026 and the action is ongoing. \n\nAffected parties should immediately identify any inventory of the BiDop 3 device and fetal probe, verify current labeling against cleared indications, and contact the firm for corrective action procedures. Healthcare providers using this device should confirm whether their clinical protocols rely on the uncleared fetal indication and adjust accordingly.

What to do next

  1. Contact Koven Technology for recall details and corrective actions
  2. Review inventory for affected Koven BiDop 3 devices and fetal probes
  3. Remove or correct any labeling claiming fetal use that is not 510(k) cleared

Archived snapshot

Apr 11, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Koven Technology, Inc.

Device Recalls (Class II)

← All Device Recalls (Class II) Class II Z-1631-2026 · 20260401 · Ongoing

Product

Brand Name: BiDop 3 Product Name: BiDop 3 Pocket Doppler (ES-100V3) with BT2M20S8C fetal probe Model/Catalog Number: ES-100V3 (device); BT2M20S8C (2 MHz fetal probe). Software Version: N/A Prod...

Reason for Recall

Product labeling includes a fetal indication for use that is not cleared under its 510(k).

Distribution

US Nationwide distribution in the states of LA, NC, MT, TX MA, OR, NY, IL, CO, GA, FL, WA, WI, MO, AZ, IN.

Source: openFDA Enforcement API

CFR references

21 CFR Part 807

Named provisions

510(k) Premarket Notification Fetal indication labeling

Get daily alerts for FDA: Device Recalls Class II

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA
Filed
April 1st, 2026
Instrument
Enforcement
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
Z-1631-2026

Who this affects

Applies to
Medical device makers Healthcare providers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical device distribution Fetal monitoring devices Labeling compliance
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Healthcare Consumer Protection

Get alerts for this source

We'll email you when FDA: Device Recalls Class II publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!